Inventor
Jacques Mauger
Inventor
Tucson, AZ, US
Overview
Patents· 15 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations31%
C07DHeterocyclic compounds28%
A61KPreparations for medical, dental or toiletry purposes10%
C07CAcyclic or carbocyclic compounds8%
C07KPeptides8%
C07JSteroids5%
G01NInvestigating or analysing materials by determining their chemical or physical properties5%
C07BGeneral methods of organic chemistry3%
C40BCombinatorial chemistry3%
PatentTitleYear
10,138,235Pyrazolopyridine derivatives, preparation process therefor and therapeutic use thereof20189,957,294Compositions and methods for analyzing histidine phosphorylation20189,850,319Generation and use of polyclonal and monoclonal antibodies specific for 3-phosphohistidine20178,791,133'Pyridylvinylpyrazoloquinolines as PAR1 inhibitors'20148,420,824'Substituted pyrazoles, compositions containing these, method of production and use'20138,410,286'Substituted pyrazoles, compositions containing these, method of production and use'20138,163,768'1,4-dihydropyridine-fused heterocycles, process for preparing the same, use and compositions containing them'20127,989,439'Substituted pyrazoles, compositions containing these, method of production and use'20117,825,115'Cyclic urea compounds, preparation thereof and pharmaceutical use thereof as kinase inhibitors'20107,354,933'Cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors'20087,279,480'Hexahydropyridazine-3-carboxylic acid hydrazide and hydrazone derivatives, combinatorial libraries containing same, pharmaceutical compositions containing same and methods of preparation'20077,223,758'Pyridazine derivative, pharmaceutical composition thereof, its pharmaceutical use, and process for its preparation'20077,034,022'Hexahydropyridazine-3-carboxylic acid derivatives, pharmaceutical compositions containing same and methods of preparation'20066,566,542'17-Halogenated 19-nor steroids, preparation process and intermediates, use as medicaments and the pharmaceutical compositions containing them'20036,423,700'17-halogenated 19-nor steroids, method and intermediates for preparing same, use as medicines and pharmaceutical compositions containing same'2002Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2002–2012Patents assigned to AVENTIS PHARMA SA (7)· patent assignee history
2002–2007Based in Paris, FR· patent location history
2006–2017Based in Tucson, AZ, US· patent location history
2012–2013Patents assigned to BJERGARDE KIRSTEN (3)· patent assignee history
2012–2013Patents assigned to MAUGER JACQUES (3)· patent assignee history
2012–2013Patents assigned to NAIR ANIL (3)· patent assignee history
2013–2018Patents assigned to SANOFI SA (5)· patent assignee history
2013Based in Tuscon, AZ, US· patent location history
2014–2018Based in Oro Valley, AZ, US· patent location history
2018Based in Bridgewater, NJ, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| AVENTIS PHARMA SA | 7 | 2002–2012 |
| SANOFI SA | 5 | 2013–2018 |
| BJERGARDE KIRSTEN | 3 | 2012–2013 |
| MAUGER JACQUESself | 3 | 2012–2013 |
| NAIR ANIL | 3 | 2012–2013 |
Locations
| Location | Patents | Span |
|---|---|---|
| Tucson, AZ, US | 7 | 2006–2017 |
| Paris, FR | 3 | 2002–2007 |
| Oro Valley, AZ, US | 2 | 2014–2018 |
| Tuscon, AZ, US | 2 | 2013 |
| Bridgewater, New Jersey, US | 1 | 2018 |